» Articles » PMID: 25862803

HIV Status and the Risk of Ischemic Stroke Among Men

Abstract

Objective: Given conflicting data regarding the association of HIV infection and ischemic stroke risk, we sought to determine whether HIV infection conferred an increased ischemic stroke risk among male veterans.

Methods: The Veterans Aging Cohort Study-Virtual Cohort consists of HIV-infected and uninfected veterans in care matched (1:2) for age, sex, race/ethnicity, and clinical site. We analyzed data on 76,835 male participants in the Veterans Aging Cohort Study-Virtual Cohort who were free of baseline cardiovascular disease. We assessed demographics, ischemic stroke risk factors, comorbid diseases, substance use, HIV biomarkers, and incidence of ischemic stroke from October 1, 2003, to December 31, 2009.

Results: During a median follow-up period of 5.9 (interquartile range 3.5-6.6) years, there were 910 stroke events (37.4% HIV-infected). Ischemic stroke rates per 1,000 person-years were higher for HIV-infected (2.79, 95% confidence interval 2.51-3.10) than for uninfected veterans (2.24 [2.06-2.43]) (incidence rate ratio 1.25 [1.09-1.43]; p < 0.01). After adjusting for demographics, ischemic stroke risk factors, comorbid diseases, and substance use, the risk of ischemic stroke was higher among male veterans with HIV infection compared with uninfected veterans (hazard ratio 1.17 [1.01-1.36]; p = 0.04).

Conclusions: HIV infection is associated with an increased ischemic stroke risk among HIV-infected compared with demographically and behaviorally similar uninfected male veterans.

Citing Articles

Comparative Bleeding Risk in Older Patients With HIV and Atrial Fibrillation Receiving Oral Anticoagulants.

Quinlan C, Avorn J, Kesselheim A, Singer D, Zhang Y, Cervone A JAMA Intern Med. 2025; .

PMID: 39992678 PMC: 11851300. DOI: 10.1001/jamainternmed.2024.8335.


Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study.

Elvstam O, Ryom L, Neesgaard B, Tau L, Gunthard H, Zangerle R Open Forum Infect Dis. 2025; 12(2):ofaf016.

PMID: 39896984 PMC: 11786055. DOI: 10.1093/ofid/ofaf016.


Optimizing cardiometabolic risk in people living with human immunodeficiency virus: A deep dive into an important risk enhancer.

Kobe E, Thakkar A, Matai S, Akkaya E, Pagidipati N, McGarrah R Am J Prev Cardiol. 2024; 20:100888.

PMID: 39552706 PMC: 11566711. DOI: 10.1016/j.ajpc.2024.100888.


Impact of arterial stiffness on health-related quality of life in older Thai adults with treated HIV infection: a multicenter cohort study.

Rerkasem A, Chotirosniramit N, Tangmunkongvorakul A, Aurpibul L, Sripan P, Parklak W Qual Life Res. 2024; 33(12):3245-3257.

PMID: 39400692 DOI: 10.1007/s11136-024-03796-9.


Emerging roles of senolytics/senomorphics in HIV-related co-morbidities.

Kaur G, Rahman M, Shaikh S, Panda K, Chinnapaiyan S, Santiago Estevez M Biochem Pharmacol. 2024; 228():116179.

PMID: 38556028 PMC: 11410549. DOI: 10.1016/j.bcp.2024.116179.


References
1.
Lee M, Yang H, Wang C, Jen C, Yeh S, Liu C . Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke. 2010; 41(12):2894-900. DOI: 10.1161/STROKEAHA.110.598136. View

2.
Hoffmann M, Berger J, Nath A, Rayens M . Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. J Neurovirol. 2000; 6(3):229-36. DOI: 10.3109/13550280009015825. View

3.
Jain R, Furfine E, Pedneault L, White A, Lenhard J . Metabolic complications associated with antiretroviral therapy. Antiviral Res. 2001; 51(3):151-77. DOI: 10.1016/s0166-3542(01)00148-6. View

4.
Ekundayo O, Vassar S, Williams L, Bravata D, Cheng E . Using administrative databases to calculate Framingham scores within a large health care organization. Stroke. 2011; 42(7):1982-7. PMC: 3125472. DOI: 10.1161/STROKEAHA.110.603340. View

5.
Freiberg M, Chang C, Skanderson M, McGinnis K, Kuller L, Kraemer K . The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes. 2011; 4(4):425-32. PMC: 3159506. DOI: 10.1161/CIRCOUTCOMES.110.957415. View